Meyer 2015.
Trial name or title | Financial incentives promote smoking abstinence among patients with pulmonary disease |
Methods | Randomised controlled trial |
Participants | 30 daily smokers diagnosed with chronic obstructive pulmonary disease (COPD) (FEV1/FVC < 70%) |
Interventions | "Participants visit the clinic daily for 14 days and provide breath and urine samples for biochemical verification of smoking status. Incentive participants earn financial incentives delivered contingent upon smoking abstinence. Controls receive vouchers of the same value but independent of smoking status." |
Outcomes | "Abstinence is defined as a breath CO level 6 ppm during Study Days 1–5 and a urinary cotinine level 80 ng/ml on Days 6–14." |
Starting date | Not stated |
Contact information | Stacey Sigmon: UHC‐SATC Room 1415, 1 South Prospect Street, Burlington, VT 05401, United States stacey.sigmon@uvm.edu |
Notes |